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1.0 EXECUTIVE SUMMARY 
 
The strategy takes into account the proposed changes in work load based on trend analysis 
of previous years and also takes into consideration the proposed changes to legislation that 
are planned for later in 2011.  
The strategy also takes into account the problem of drugs and driving and the need for the 
Medical Bureau of Road Safety to accommodate both the number of specimens for analysis 
and also the type of drugs to be analysed. The Bureau has also to plan for the introduction 
of roadside drug testing. 
 
 
1.1  MISSION 
 
The Mission of the Medical Bureau of Road Safety (Bureau) is to provide a high quality 
national forensic service in alcohol/drug (intoxicant) detection in support of the effective 
operation of the road traffic legislation. 
 
 
1.2  5 YEAR OBJECTIVES 
 
1. To continue to provide a high quality national forensic service in alcohol and drug 
analysis, the provision of Bureau certificates and Court assistance. 
 
2. To maintain the ISO17025 accredited status achieved for the different analytical 
programmes within the Bureau and to extend the scope of accreditation to additional 
areas. 
 
3. To adapt and incorporate into the Bureau activities any legislative requirements over 
the five year period. 
 
4. To build up a forensic toxicology (including alcohol) knowledge base within the Bureau 
scientific staff. 
 
5. To reduce the current requirement of out sourcing confirmatory drug analysis.  
 
6. To increase Garda capacity to detect drug drivers at the roadside.  
 
7. To ensure that all work in the Bureau is maintained and improved where possible to a 
high standard of quality that is required of a national forensic laboratory in a cost 
effective and efficient way. 
 
8. To assist with education, enforcement and legislation measures as outlined in the 
current National Road Safety Strategy 2007 to 2012 and in the next National Road 
Safety Strategy. 
 
9. To maintain effective financial management systems and operate within best 
accounting practices and frameworks. 
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10.  To ensure that the Bureau has Corporate Governance in operation and has the ability 
to objectively and effectively assess management and corporate performance. 
 
 
 
1.3  KEYS TO SUCCESS 
 
In order for the Bureau to achieve its objectives it relies on good planning, provision of 
adequate resources, staff and instrumentation for the detection of alcohol and /or drugs. 
 
 
Planning 
 
The Bureau is a service organisation and in order to provide an efficient service it must 
know the requirements of its clients. The Bureau communicates regularly with both the 
Department of Transport (DOT) and The Garda National Traffic Bureau (GNTB) in relation to 
the service being provided and the legislative and operational changes that are required to 
continue to provide a reliable and efficient service in support of the road traffic legislation.  
 
Careful planning for the most efficient use of resources of the Bureau is constantly required. 
 
Resources 
 
The Bureau depends totally on the grant given by the DOT and tries to plan and work within 
that budget. However it is the work of the Gardaí that dictate the volume and nature of the 
work that is carried out by the Bureau, i.e. the number of specimens forwarded and the 
whether it is alcohol and/or drug analysis that is required.  The need to maintain supplies of 
specimen collection kits to stations, roadside devices calibrated and tested, evidential breath 
test instruments calibrated and tested in stations requires adequate resources. The Bureau 
must deliver both quality and value for money and continually reviews its activities to ensure 
it operates in a cost effective manner. 
 
Staffing 
 
The analytical work and associated activities requires high knowledge base staff. Sufficient 
staff to carry out the functions of the Bureau is essential. The law requires that analysis and 
issuing of results are carried out as soon as practicable. All scientific staff require suitable 
and continuous training to maintain their competence and be suitable expert witnesses. The 
reputation of the Bureau has been built up over forty years of good scientific and 
administrative practice and each staff member works hard to maintain the high standard 
required of a national forensic laboratory. 
 
Instrumentation 
 
The Bureau cannot operate without instrumentation and continues to provide the laboratory 
with suitable analytical instruments keeping abreast of innovation in technology both in the 
field of alcohol and drug detection. The Bureau also issue the Gardaí with suitable 
instrumentation for evidential breath testing in selected Garda stations and suitable devices 
for roadside breath alcohol testing. The Bureau will continue to investigate the 
developments in roadside drug testing devices. The Bureau requires that its testing 
equipment is in calibration and in good working order. 
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2.0  MANAGEMENT SUMMARY 
 
The Board of the Bureau comprises of five members (including the Director) which is 
appointed by the Minister of Transport for a five year term. The current Board members are 
Professor Cecily Kelleher (Chairman), Professor Denis Cusack (Director), Mr Declan Hayes, 
Mr Philip Joyce and Dr Niall Mc Namara. 
 
The Director is responsible for managing the day to day business of the Bureau. 
The Bureau has made an arrangement with UCD for the use by the Bureau of its staff, 
premises and equipment for the majority of its functions.  
The Bureau has made an arrangement with the LGC for the use by the Bureau of its staff, 
premises and equipment for selected confirmatory analysis for drugs. 
 
The functions of the Bureau are divided into different programmes and services: Blood & 
Urine Alcohol, Breath Alcohol, Toxicology and Corporate Services. 
All areas have been developed and expanded in recent years in line with increase in 
demands in all aspect of the work of the Bureau.  
 
 
2.1  ORGANISATIONAL STRUCURE 
   
A diagrammatic presentation of the organisational structure of the Bureau is outlined on the 
next page.  
 
 
2.2  EXECUTIVE MANAGEMENT TEAM 
 
Director: Professor Denis Cusack  
Head of Laboratories (Chief Analyst): C.P.Leavy 
Principal Analyst Breath Alcohol Test Programme: D.Reynolds 
Principal Analyst Blood & Urine Alcohol Programme: H.Kearns 
Principal Analyst Toxicology Programme: Dr R. Maguire 
Head of Administration (Senior Administrator): T.Clarke 
 
Quality Manager: H.Kearns 
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3.0             ESTABLISHMENT OF THE MEDICAL BUREAU OF ROAD SAFETY 
 
The Medical Bureau of Road Safety (Bureau) is responsible for the chemical testing of 
intoxicants in driving in Ireland. It is a corporate body established in November 1968 by 
the Minister for Local Government under Part V of the Road Traffic Act 1968.The 
Ministers title was altered to Minister for the Environment & Local Government 22nd July 
1997. In June 2002 the Medical Bureau of Road Safety came under the aegis of the 
Minister for Transport following the transfer of departmental Administration and 
Ministerial Functions Order 2002. 
 
3.1  FUNCTIONS OF THE MEDICAL BUREAU OF ROAD SAFETY 
 
The Functions of the Bureau are laid down in the Road Traffic Acts 1968 – 2010  
• Receipt and analysis of specimens of blood and urine specimens forwarded to the 
Bureau and the issue of reports on such analysis—for the concentration of 
alcohol. 
• Receipt and analysis of specimens of blood and urine specimens forwarded to the 
Bureau and the issue of reports on such analysis—for the presence of a drug or 
drugs 
• Provision of equipment for the taking of such specimens 
• Approval, supply and testing of apparatus for indicating the presence of alcohol in 
the breath 
• Approval, supply and testing of apparatus for indicating the concentration of 
alcohol in the breath 
• Provide assistance to the Court  
• Research on drinking and drugs in relation to driving, including the methods of 
determining the amount of alcohol or drugs in a person’s body and the 
epidemiology of driving under the influence of intoxicants 
 
4.0   GOAL 
 
It is the continuing policy of the Medical Bureau of Road Safety (Bureau) to achieve and 
maintain a high standard of quality in all aspects of the work of the Bureau. 
 
4.1       OBJECTIVES 
 
The programme of work for the Medical Bureau of Road Safety will continue to focus on 
the main legal responsibilities as set out in the Road Traffic Acts and the action plan of 
the National Road Safety Strategy 2007-2012.   
 
4.2   SHORT- TERM GOALS (1 -2 YEARS) 
 
Blood & Urine Alcohol Programme 
 
1. To maintain ISO 17025 accredited status for blood and urine alcohol analysis 
carried out in the Bureau. (point 2 of the 5 year objectives) 
 
2. To maintain the provision of equipment to Gardaí for the taking of specimens. 
(point 1 of 5 year objectives) 
 
3. To facilitate the implementation of proposed new alcohol limits.                        
(Point 3 of 5 year objectives) 
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Breath Alcohol Programme 
 
4. To maintain ISO 17025 accredited status for performance testing of evidential 
breath alcohol testing instruments installed in Garda stations by Bureau 
scientists. (Point 2 of 5 year objectives) 
 
5. To facilitate the implementation of proposed new alcohol limits. 
(Point 3 of 5 year objectives) 
 
6. To continue to support the Gardaí in the operation of the EBT instruments in 
Garda stations. (Point 1 of 5 year objectives) 
 
7. To continue to support the mandatory alcohol legislation. (Point 1 of 5 year 
objectives) 
 
Toxicology Programme 
 
8. To maintain ISO 17025 accredited status for preliminary blood and urine 
 drug analysis carried out in the Bureau. (Point 2 of 5 year objectives) 
 
9. To extend the scope of accreditation in the toxicology programme (Point 2 of 
5 year objectives) 
 
10. To phase out the requirement for outsourcing the confirmatory analysis 
 to the LGC laboratory. (Point 5 of 5 year objectives) 
 
11. To support the training of Garda instructors in Road Traffic Impairment 
Testing (Point 6 of 5 year objectives) 
 
12. To build up knowledge of roadside drug testing. (Point 6 of 5 year 
 objectives) 
 
 
All programmes 
 
13. To continue to provide court assistance. (Point 1 of 5 year objectives) 
 
14. To build up a forensic toxicology (including alcohol) knowledge base within 
the staff of the Bureau.  (Point 4 of 5 year objectives) 
 
15. To ensure that the Bureau facilitates the Official Languages Act.  (Point 3 of 5 
year objectives) 
 
16. All work in the Bureau will be maintained and improved where possible to a 
high standard of quality that is required of a national forensic laboratory. 
(Point 7 of 5 year objectives) 
 
17. To improve and develop the recording, storage and retrieval of data in the 
Bureau. (Point 7 of 5 year objectives) 
 
18. To assist with education, enforcement and legislation measures as  
       outlined in the National Road Safety Strategy 2007 to 2012. 
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Corporate Services 
 
19. To ensure that the Bureau has its structures and processes in place to      
      conform to the Code of Practice for the Governance of State Bodies.  
      (Point 10 of 5 year objectives). 
 
20. To improve and develop the management of the accounting records and  
      data in the Bureau.  (Point 9 of 5 year objectives). 
 
4.3   LONG- TERM GOALS (3- 5 YEARS) 
 
Alcohol Programme 
 
1. To maintain ISO 17025 accredited status for blood and urine alcohol analysis 
carried out in the Bureau. (Point 2 of 5 year objectives) 
 
2. To maintain the production and issue of equipment (kits) for the provision of 
blood and urine specimens as required by the Gardaí. (Point 1 of 5 year 
objectives) 
 
EBT Programme 
 
3. To maintain ISO 17025 accredited status for performance testing of evidential 
breath alcohol testing instruments installed in Garda stations by MBRS scientists. 
(Point 2 of 5 year objectives) 
 
4. To continue to support the Gardaí in the operation of the EBT instruments in 
Garda stations. (Point 1 of 5 year objectives) 
 
5. To continue to support the mandatory alcohol legislation. (Point 1 of 5 year 
objectives) 
 
Toxicology Programme 
 
6. To maintain ISO 17025 accredited status for preliminary blood and urine drug 
analysis carried out in the Bureau. (Point 2 of 5 year objectives) 
 
7. To expand the drug confirmatory programme within the Bureau at UCD premises. 
(Point 5 of 5 year objectives) 
 
8. To maintain and extend the scope of accreditation for the drug confirmatory 
analyses as new methods are developed. (Point 7 of 5 year objectives) 
 
9. To plan and implement a roadside drug device testing programme. (Point 6 of 5 
year objectives) 
 
All Programmes 
 
10. To continue to provide court assistance. (Point 1 of 5 year objectives) 
 
11. To continue to build up a forensic toxicology (including alcohol) knowledge 
 base within the staff of the Bureau (Point 4 of 5 year objectives) 
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12. To facilitate any further legislative changes that may be planned. (Point 3 of 5 
 year objectives) 
 
13. To ensure that all work in the Bureau will be maintained and improved where 
 possible to a high standard of quality that is required of a national forensic 
 laboratory. (Point 7 of 5 year objectives) 
 
14. To assist with education, enforcement and legislation measures as outlined in 
 the relevant National Road Safety Strategy. (Point 8 of 5 year objectives) 
 
Corporate Services 
 
15. To continue to achieve that the structures and processes in place conform to the 
Code of Practice for the Governance of State Bodies. (Point 10 of 5 year objectives). 
 
16. To ensure that financial management will be maintained in accordance with best 
accounting practice and frameworks. (Point 9 of 5 year objectives). 
 
 
5.0        CHALLENGES FACING THE MEDICAL BUREAU OF ROAD 
 SAFETY 
 
• The provision of sufficient resources both in budget and staffing for the Bureau to 
meet the legal requirements of carrying out its functions. 
• Constant legal challenges to the existing work carried out in the Bureau. 
• Introduction of new alcohol limits in 2011 and the knock on effects for the alcohol 
and EBT programmes within the Bureau.  
• Legal challenges when new legislation is introduced.  
• The numbers of drug drivers being detected and the drug analysis required. 
• The implementation of new and different technologies for the different classes of 
drugs. 
• The need for monitoring trends of general drug use in order to determine which 
drugs to analyse for. 
• Developments in roadside and laboratory drug testing. 
• Maintenance and expansion of accreditation to ISO 17025 for all analytical 
testing. 
• Building and maintaining a knowledge based analytical staff and keeping abreast 
of developments in the related scientific fields.  
 
 
5.1        COPERATING ENVIRONMENT 
 
The Bureau currently operates under the Road Traffic Acts 1968 to 2010 and the National 
Road Safety Strategy 2007 to 2012 
 
The Bureau also has legal obligations under the Bureau Establishment Order 1968 to the 
Minister of Transport 
 
• Provide the Minister with an Annual Report 
• Provide the Minister with a copy of the annual accounts and the auditor’s 
certificate 
• Provide the Minister with information from time to time which may be required 
regarding the functions of the Bureau.  
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The Bureau is subject to FOI since 2005. Clarification of the records subject to FOI was 
made under the RTA 2010. 
 
The Bureau also conforms to the Code of Practice for the Governance of State Bodies. 
 
 
5.2   RISK MANAGEMENT PROCESS 
 
Risk management is included as an integral component of the Medical Bureau of Road 
Safety’s planning process in relation to the operational, financial and reputational risks 
that may affect the body.    
 
5.3   CORPORATE RISK ANALYSIS 
 
On an annual basis, the Board evaluates its approach to risk management and the 
process that the Bureau has in place to mitigate any identified/potential risks. 
 
5.4   RISK CONROLS 
 
Key aspects of the Bureau’s risk management system include: 
 
• Identifying the nature, extent and possible implication of risks facing the Bureau 
• Assessing the likelihood of identified risks occurring 
• Assessing the ability to manage and mitigate risks that do occur 
 
A risk management policy and register is in operation and will continue to be annually 
reviewed. 
 
6.0   STRATEGY & IMPLEMENTATION SUMMARY 
 
The three major programmes within the Bureau have three different strategies and 
implementation plans. All however can be subdivided in to the following categories: 
analysis (testing), Quality assurance, equipment requirements, court attendances, 
maintenance and increase of forensic toxicology (including alcohol) knowledge base of 
the Bureau. All programmes will be working towards achieving the goals set out both in 
the short term and in the long term. 
 
 
6.1  IMPLEMENTATION OF OBJECTIVES 
 
Alcohol Programme 
 
Alcohol Analysis 
 
The Bureau will continue to analyse blood and urine specimens for alcohol concentration 
using Gas Chromatography (GC) Headspace analysis. Each specimen is analysed twice by 
two different analysts using two different GC instruments with different chromatographic 
columns. This is international best practice.   (See important assumptions, section 7.1) 
 
The analytical process will be reviewed in the context of the proposed reduction in legal 
limits. (Point 3 of 5 year objectives) 
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Quality Assurance 
 
The Bureau will continue to operate a quality assurance programme in this area in order 
to comply with the requirements of the ISO 17025 standard. (Point 2 of 5 year 
objectives) 
 
Equipment 
 
The need for constant use of instruments also requires the constant review of the 
suitability of the equipment and replacement equipment will be required during the 
lifetime of this strategy. (Point 1 of 5 year objectives) 
 
Equipment for the Provision of Specimens 
 
The specimen collection kits for the provision of specimens forwarded to the Bureau is 
prepared and provided to the Gardaí by the Bureau. (Point 3 of 5 year objectives) 
It is envisaged that the Bureau will continue to maintain its kit output annually in line 
with demand.  (See Important Assumptions Section 7.1) (Point 1 of 5 year objectives) 
 
The legislation for the reduction in the limit planned for 2011 necessitates maintaining 
current levels of the existing type of kits and preparing the new replacement kits at the 
same time. The introduction of the new kits has already commenced and the removal of 
the old kits is required and disposal will take place in 2012. (Point 3 of 5 year objectives) 
 
EBT Programme 
 
Evidential Breath Testing (EBT) 
 
Quality Assurance  
The Bureau obtained accreditation under ISO 17025 in 2003 for testing the EBT 
instruments in stations. It will continue to maintain this level of quality assurance in its 
testing programme for the lifetime of the strategy. (Point 2 of 5 year objectives) 
 
Instruments 
 
The current compliment of evidential breath testing instruments in Garda stations is 64.  
The first instruments were installed in stations in 1999.  
Procurement procedures for replacement instruments commenced in 2009 for the 
introduction of the proposed new alcohol legal limits in 2011. It has been agreed that the 
Gardai would be supplied with 86 instruments for installation in Garda stations.  A total of 
100 instruments will be purchased over the lifetime of the plan in order to maintain the 
programme including several dedicated for training purposes. The Bureau has prepared a 
strategy for the introduction of new instruments and agreed a timeframe with the DOT 
and the Gardai. A separate implementation plan will be prepared and the Bureau will 
work closely with the Gardai in relation to the detailed scheduling of the replacement 
instruments. The Bureau will continue to maintain the current programme while 
preparing for the new programme. (Point 3 of 5 year objectives) 
 
Schedule of Visits and Level of Testing 
 
Under the RTA the MBRS is responsible for the forensic integrity of the instruments and 
will continue to maintain the instruments in good working order.  This involves Bureau 
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scientists testing the instruments installed in stations at least twice a year, following the 
annual service visit and at a six monthly interval.  
Non-scheduled visits will be carried out in response to fault calls made by the Gardaí on 
an as soon as practicable basis.  
With the introduction of mandatory alcohol testing some busy urban Garda stations 
require additional visits by Bureau scientists to download data on a more frequent basis. 
(Point 1 of 5 year objectives) 
The Bureau scientists will visit additional stations due to the increase in the number of 
instruments planned for installation.  
 
Training of Garda operators and supervisors  
 
A conversion course was devised in conjunction with the Garda Training College as 
planned for 2011 and is currently being implemented by Bureau scientists for the 
introduction of the new instruments in 2011. (Point 3 of 5 year plan)  A new course will 
be devised for new operators for 2012 onwards. (Point 3 of 5 year objectives) 
 
 Working group for EBT Programme  
 
A working group consisting of the MBRS, the GNTB and the DOT has been formed to plan 
and implement the changeover in instrumentation for the new alcohol limits. (Point 3 of 5 
year objectives) 
 
Preliminary Alcohol Breath Testing (Roadside Testing) 
 
Quality Assurance  
 
The Bureau obtained accreditation under ISO 17025 in 2009 for testing the Preliminary 
Breath Testing (PBT) devices. It will continue to maintain this level of quality assurance in 
its testing programme for the lifetime of the strategy. (Point 2 of 5 year objectives) 
 
Equipment 
 
Over 1,000 Draeger 6510 devices have been issued to the Gardaí since 2005 and are 
being converted to dual limit devices for the introduction of the 2010 Road Traffic Act.  
By 2012 all devices issued will be dual limit devices.  It is envisaged that only 
replacement devices will be purchased during the lifetime of this strategy. (Point 1 of 5 
year objectives) 
 
Provision of Mouthpieces to Gardaí  
 
Current use is estimated that 600,000 mouthpieces which are issued annually and this 
number will be constantly reviewed in order to maintain the mandatory alcohol testing 
legislation and the additional provision with regard to breath testing at scene of crashes 
introduced in the RTA 2011. (Point 8 of 5 year objectives) 
 
Routine Testing 
 
Each device is scheduled for recalibration on a bi-annual basis. The Bureau will continue 
to test and calibrate the Draeger 6510 screening devices in the laboratory. The Bureau 
will continue to support the devices in the scheduling of the return and the testing and re 
issuing of these devices. (Point 1 of 5 year objectives) 
Towards the end of the lifetime of this 5 year strategy the Bureau will need to review the 
current devices and commence planning for replacement of the devices.  
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Toxicology Programme 
 
Drug Analyses 
 
Preliminary analysis  
 
The Bureau will continue the analysis of all blood and urine specimens found under the 
limits for alcohol, for the presence of drug or drugs.   The numbers for analysis has 
decreased in line with the numbers of specimens received in the Bureau. However with 
the change in legislation due in 2011 and the road traffic impairment 
testing(RTIT)training due to be received by gardai in 2011 the numbers may increase 
towards the end of 2011. (See important assumptions, section 7.1) 
 
Gardaí can continue to request drug analyses on specimens with alcohol levels above the 
legal limit and also for specimens where an EBT statement for breath alcohol content has 
already been issued.  (Point 1 of 5 year objectives) 
 
Quality Assurance  
 
The Bureau has obtained accreditation to ISO 17025 for the preliminary analyses carried 
out in the Bureau in 2009 and will continue to operate a quality assurance programme in 
this area to retain its ISO 17025 accredited status. (Point 2 of 5 year objectives) 
 
Confirmatory analysis  
 
Confirmatory drug analysis was established in house in early 2010 commencing with the 
analysis of blood and urine specimens for the presence of cannabinoids using Gas 
Chromatography Mass Spectrum technology (GCMS). The Bureau also introduced in 
house confirmatory analysis for benzodiazepines in urine specimens in early 2011 using 
Liquid Chromatography Mass Spectrum technology (LCMS).   It is planned to have the 
confirmatory analysis for benzodiazepines in blood also in house by end 2011. It is also 
planned to advance the technology in order to expand the confirmatory testing 
programme carried out in the Bureau by end 2012.  In the meantime the Bureau will 
continue to outsource confirmatory analysis as appropriate.   (See Important Assumption, 
Section 7.1s) (Point 5 of 5 year objectives) 
 
Equipment  
 
The Bureau will continue to maintain the existing equipment for the blood and urine 
preliminary drug testing programme for as long as possible but will need to investigate 
other options which are coming on the market in order to be ready to replace them when 
required which may be at short notice.  (Point 1 of 5 year objectives) 
The Bureau has invested in additional instrumentation for the detection and confirmatory 
drug analysis in 2010/2011. Additional sample preparation instrumentation will be 
required during the life time of this strategy.  Also older instruments will be kept under 
review and may need to be replaced towards the end of this five year strategy period. 
(Point 7 of 5 year objectives) 
 
 
Quality Assurance  
 
The Bureau will seek extension to scope of its accreditation to ISO 17025 to include the 
methods used in confirmatory analysis as they are developed.  (Point 2 of 5 year 
objectives) 
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Roadside Drug Testing 
 
The Bureau was the lead agency in establishing drug impairment education programmes 
for an Garda Siochana, doctors and nurses under the Road Safety Strategy 2007 -2012 
and  Bureau scientists have participated in the devising of the courses and also in the 
delivery of course content.  Bureau scientists will continue to participate in future 
courses.  
 
The Bureau will continue to monitor developments in roadside drug testing technologies 
and will continue to review the possibility of introducing roadside drug testing devices to 
the Gardaí. The Bureau will plan and implement the provision of a suitable roadside drug 
testing device in agreement with the DOT and GNTB. The Bureau will continue to 
participate in any surveys or research in this area. (Point 6 of 5 year objectives) 
 
 
Research 
 
Drugs and driving (DUID) continues to be an area of concern to the Government 
especially with regard to enforcement.  The type of research area that the Bureau will be 
involved in will be decided by the Director, in consultation with the Department of 
Transport (DOT), as part of the Government’s Road Safety Strategy.  (Point 8 of 5 year 
objectives) 
 
 
All Programmes 
 
Court Attendances 
 
The requests by Prosecution and Defence solicitors for MBRS scientists to attend courts 
nationwide and present evidence with regard to Bureau analysis for alcohol and drugs 
and for evidential breath alcohol testing is part of the service of the Bureau. It is 
envisaged that legal challenges will continue to demand the time of both administrative 
and analytical staff both in and out of court. With the introduction of the new legislation 
this activity is expected to increase and become more demanding of staff time and 
expertise. (Point 1 of 5 year objectives) 
 
Forensic Toxicology (Including Alcohol) Knowledge – Base Within The Bureau 
 
The quantity and quality of the work of the Bureau depends greatly on the quantity and 
quality of the staff in the Bureau. It is extremely labour/instrumentation intensive with a 
high knowledge base staff requirement.  All analytical staff have a third level 
qualifications and most have fourth level qualifications. The Bureau currently requires 
additional scientific staff to provide support for all programmes and without this support  
the implementation of the functions of the Bureau will continue to be carried out to the 
highest standard but at a reduced level. The goals and implementation plans will be 
adapted to reflect the shortfall in staff requirements.   
Analysts are required to follow well planned training programmes to completion before 
being permitted to sign a statutory certificate on behalf of the Bureau.  
Forensic alcohol and toxicological knowledge is acquired by several routes, by 
qualification, professional memberships, reading relevant scientific journals, attendance 
at courses, conferences and meetings, building up relationships with similar laboratories 
within the country and overseas.  All analysts are expected to conduct self directed 
learning. (Point 4 of 5 year objectives) 
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General Staff Development 
 
All permanent staff have been involved in the PMDS process within UCD and suitable 
courses have been agreed which are relevant to the work of the Bureau and for their 
own personal development. (Point 7 of 5 year objectives) 
 
Laboratory Information Management System (LIMS) 
 
The Bureau purchased a LIMS in 2010 and the first phase of the implementation strategy 
was completed by mid 2011.   The strategy commenced with the blood and urine alcohol 
programme and will then expand to include the toxicology programme and a separate 
programme for the breath alcohol programme will then be devised.  The Bureau is 
currently expanding its Local Area Network system (LAN) which was installed in 2009 and 
plans to add additional data bases to the system.  (Points 7 & 8 of 5 year objectives). 
The LAN is providing much needed assistance with managing the Bureaus many 
functions.   
 
Quality Management System 
 
To maintain quality documentation in line with ISO 17025 requirements, the Bureau 
installed an electronic form of document management in 2010 and it is now fully 
operational.  (Points 1, 2 & 7 of 5 year objectives) 
 
Corporate Services 
 
To improve the efficiency within financial management it is planned to implement a 
purchasing processing system (POP) and for it to be fully operational in 2011.  (Point 9 of 
5 year objectives) 
 
 
6.2  PERFORMANCE INDICATORS 
 
The main performance indicator for the quality of the work of the Bureau is in the 
maintenance of its ISO accreditation status for the analytical activities accredited. 
There are also specific performance indicators for the specific programmes. 
 
In the Alcohol Programme the specific indicators are  
 
• The specimens will continue to be analysed as soon as practicable within the 
meaning of the legislation.  
• A sufficient number of the analytical staff will be trained to competent level to 
carry out the analysis and be capable of providing expert witness testimony on 
behalf of the Bureau.  
• The levels of specimen collection kits will continue to be provided to the Gardaí to 
meet their requirements. 
• That provision of specimen collection kits to support proposed new legislation will 
be provided to meet both Garda and DOT requirements. 
 
In the Evidential Breath Testing Programme the specific indicators are 
 
• A sufficient number of the analytical staff will be trained to competent level to 
carry out the testing of instruments and devices and be capable of providing 
expert witness testimony on behalf of the Bureau.  
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• As many as possible of the 64 instruments in stations and the 1,000 breath 
alcohol screening devices will be maintained and available for use by Garda 
operators at any given time.  
• The Bureau to provide training of operators and supervisors as required by the 
Gardaí. 
• The Bureau to provide the number of instruments in stations as required by 
Gardaí in an agreed timeframe subject to available funding.  
• The Bureau to provide the Gardaí with new courses for operators/supervisors in 
an agreed time frame.  
• The Bureau will provide and maintain sufficient roadside breath testing devices as 
required by the Gardai subject to available funding. 
 
In the Toxicology Programme the specific indicators are 
 
• The specimens will continue to be analysed as soon as practicable within the 
meaning of the legislation. 
• A sufficient number of the analytical staff will be trained to competent level to 
carry out the analysis and be capable of providing expert witness testimony on 
behalf of the Bureau.  
• Confirmatory analysis for 2 drug classes to be set up, validated and in use at the 
Bureaus premises at UCD, by end of 2011. 
• Further drug classes to be set up, validated and in use by end of 2012 at Bureau 
premises at UCD. 
• Confirmatory analysis to be reviewed in 2012 and changes in drug trends to assist 
in the choice of drug classes to be added or deleted for the remainder of the 
strategy. 
• Achieve accreditation for confirmatory drug analysis as the methods are 
implemented. 
• Provide assistance with training of Garda instructors in Road Traffic Impairment 
Testing. 
• Provide the Gardaí with roadside drug testing devices provided research indicates 
there are such devices available capable of carrying out the task and suitable 
legislation and funding is in place. 
 
In the Corporate Services the specific indicators are 
 
• The monthly accounting statements will continue to be reconciled as soon as 
practicable. 
• Preparation of the annual financial statements for audit by the Comptroller and 
Auditor General in a timely manner. 
• Preparation of essential reports as required under the Code of Practice for the 
Governance of State Bodies. 
 
 
 
6.3               ACHIEVEMENTS AGAINST PERFORMANCE INDICATORS 
 
The main achievement of the Bureau is the continued acceptance by the courts of the 
forensic results issued by the Bureau.  Achievements by the Bureau will be measured by 
the quality and quantity of the service provided in alcohol and drug analyses and the 
supply of equipment for the provision of the specimens.  
It will also measure achievements against the supply and testing of the EBT instruments 
and the roadside testing devices to the highest forensic standards.  
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The continuing maintenance of accreditation to ISO 17025 standard for the activities 
already accredited and to achieve accreditation for the drug confirmatory analysis.  
Reduction achieved in the numbers of specimens being outsourced for confirmatory 
analysis. 
 
Effective financial management systems as measured by internal audits and audits of the 
Comptroller and Auditor General. 
 
 
7.0 5-YEAR FINANCIAL PLAN 
 
 
The Medical Bureau of Road Safety receives its funding from an annual grant out of the 
vote for the Department of Transport.   
 
The budget requirements are based on the performance indicators set out within the 
strategic plans.    
 
7.1  IMPORTANT ASSUMPTIONS 
 
The Bureau in devising its 5 year financial plan has based it on the following assumptions 
of:  
• The 2010 RTA incorporating the functions of the Bureau will be commenced in 
2011. 
• Expected workloads within the different programmes are as outlined in table 1 
below. 
• Scientific staffing levels will be continued at current level.  
• Instrumentation is provided for the individual programmes including EBT. 
• Roadside drug testing kits are excluded (a complete unknown price structure at 
the present) and will need further consideration at the strategic planning stage. 
• Performance assumptions as outlined in Table 1. 
• Allowance has been made within the projected capital estimate for replacement of 
essential laboratory equipment but does not allow for any significant breakdown 
within any of the programmes. 
• The Bureau has estimated the expenditure within the building utilities based on 
the costings for the previous three years. 
• The Bureau has yet to determine the overall operational requirements for the 
expansion of the toxicology programme as requirements are determined on a 
drug by drug class basis. 
• The Bureau has included development costs for the toxicology programme over 
the lifetime of the strategy. 
 
7.2 Key Financial Indicators 
 
The main key financial indicators for the effectiveness of financial management for the 
Bureau are: 
 
Funding - The Bureau to continue to obtain sufficient funding to operate all of its 
functions. 
 
Financial Cost Effectiveness - The Bureau is committed to continuing to maintain 
financial cost effectiveness by annually reviewing its suppliers and monitoring 
expenditure within all areas.    The Bureau under a Licence Agreement with University 
College Dublin has the availability of being able to utilise a number of shared services i.e. 
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IT, utilities, HR expertise, Bursars Office, Procurement services and many others.  On an 
annual basis the Bureau re-negotiates service level agreements in order to ensure best 
practice. 
 
Continuation of use of Preferred Suppliers Listings – The Bureau to continue to 
use agreed preferred suppliers on the UCD lists when possible. 
 
 
7.3 Projected Financing Requirements 
 
Appendix 1 shows the financing requirements during the period 2012 – 2016. 
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APPENDIX 1 
 
PROJECTED INCOME AND EXPENDITURE ACCOUNT 
 
2012 – 2016 
INCOME 
 
  
2012 
 
2013 
 
2014 
 
2015 
 
2016 
 € € €   
Oireachtas Grant 4,861,500 4,565,500 4,588,500 4,685,500 4,643,500 
      
 4,861,500 4,565,500 4,588,500 4,685,500 4,643,500 
 
EXPENDITURE 
 
  
2012 
 
2013 
 
2014 
 
2015 
 
2016 
PAY      
Salaries and Wages 2,622,000 2,601,000 2,644,000 2,686,000 2,729,000 
NON PAY      
Alcohol Programme 792,500 797,500 802,500 807,500 807,500 
EBT Programme 535,000 545,000 555,000 555,000 565,000 
Toxicology Programme 242,000 **252,000 **257,000 267,000 272,000 
Breath Screening Programme 160,000 160,000 160,000 160,000 160,000 
IT Programme 60,000 60,000 60,000 60,000 60,000 
CAPITAL      
Capital 450,000 **150,000 **110,000 150,000 50,000 
Totals 4,861,500 4,565,500 4,588,500 4,685,500 4,643,500 
 
Surplus/(Deficit) for Year 
 
Nil 
 
Nil 
 
Nil 
 
Nil 
 
Nil 
 
**   Roadside Drug Testing Devices – Capital not included 
**   Roadside Drug Testing Kits – Consumables not included 
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Table 1 
Performance Assumptions 
     
Alcohol 
Programme 
 2012 2013 2014 2015 2016 
        
Number of specimens  4,000 4,000 4,000 4,000 4,000 
Number of kits prepared 12,000 8,000 8,000 8,000 8,000 
Number of kits issued 12,000 8,000 8,000 8,000 8,000 
        
Toxicology Programme      
        
Number of specimens       
Preliminary analyses 2,186 2,240 2,240 2,240 2,240 
Confirmatory analyses 1,639 1,680 1,680 1,680 1,680 
        
Breath Testing 
Programme 
      
      
EBT      
No of instruments supported 86 86 86 86 86 
Testing in stations/laboratory 190 200 200 200 200 
No of training courses      
Operator   20 20 20 20 20 
Supervisor  10  10  10 10  10 
       
PBT       
No of devices 
supported  
 1,000 1,000 1,000 1,000 1,000 
       
 
